Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1106

1.

Druggable genome in attention deficit/hyperactivity disorder and its co-morbid conditions. New avenues for treatment.

Hegvik TA, Waløen K, Pandey SK, Faraone SV, Haavik J, Zayats T.

Mol Psychiatry. 2019 Oct 18. doi: 10.1038/s41380-019-0540-z. [Epub ahead of print]

PMID:
31628418
2.

Psychiatric Genetics, Epigenetics, and Cellular Models in Coming Years.

Liu C, Faraone SV, Glatt SJ.

J Psychiatr Brain Sci. 2019;4. pii: e190012. doi: 10.20900/jpbs.20190012. Epub 2019 Aug 22.

3.

Evaluating chronic emotional dysregulation and irritability in relation to ADHD and depression genetic risk in children with ADHD.

Nigg JT, Karalunas SL, Gustafsson HC, Bhatt P, Ryabinin P, Mooney MA, Faraone SV, Fair DA, Wilmot B.

J Child Psychol Psychiatry. 2019 Oct 12. doi: 10.1111/jcpp.13132. [Epub ahead of print]

PMID:
31605387
4.

Exploring genetic variation that influences brain methylation in attention-deficit/hyperactivity disorder.

Pineda-Cirera L, Shivalikanjli A, Cabana-Domínguez J, Demontis D, Rajagopal VM, Børglum AD, Faraone SV, Cormand B, Fernàndez-Castillo N.

Transl Psychiatry. 2019 Oct 3;9(1):242. doi: 10.1038/s41398-019-0574-7.

5.

Achievement goal orientation and stimulant misuse in college students.

Antshel KM, Parascandola T, Taylor LE, Faraone SV.

J Am Coll Health. 2019 Sep 9:1-9. doi: 10.1080/07448481.2019.1656635. [Epub ahead of print]

PMID:
31498751
6.

A polygenic resilience score moderates the genetic risk for schizophrenia.

Hess JL, Tylee DS, Mattheisen M; Schizophrenia Working Group of the Psychiatric Genomics Consortium; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Børglum AD, Als TD, Grove J, Werge T, Mortensen PB, Mors O, Nordentoft M, Hougaard DM, Byberg-Grauholm J, Bækvad-Hansen M, Greenwood TA, Tsuang MT, Curtis D, Steinberg S, Sigurdsson E, Stefánsson H, Stefánsson K, Edenberg HJ, Holmans P, Faraone SV, Glatt SJ.

Mol Psychiatry. 2019 Sep 6. doi: 10.1038/s41380-019-0463-8. [Epub ahead of print]

PMID:
31492941
7.

Predictive utility of autistic traits in youth with ADHD: a controlled 10-year longitudinal follow-up study.

Joshi G, DiSalvo M, Faraone SV, Wozniak J, Fried R, Galdo M, Belser A, Hoskova B, Dallenbach NT, De Leon MF, Biederman J.

Eur Child Adolesc Psychiatry. 2019 Aug 29. doi: 10.1007/s00787-019-01384-8. [Epub ahead of print]

PMID:
31468149
8.

Translating Discoveries in Attention-Deficit/Hyperactivity Disorder Genomics to an Outpatient Child and Adolescent Psychiatric Cohort.

Vuijk PJ, Martin J, Braaten EB, Genovese G, Capawana MR, O'Keefe SM, Lee BA, Lind HS, Smoller JW, Faraone SV, Perlis RH, Doyle AE.

J Am Acad Child Adolesc Psychiatry. 2019 Aug 14. pii: S0890-8567(19)31455-8. doi: 10.1016/j.jaac.2019.08.004. [Epub ahead of print]

PMID:
31421235
9.

Association of Psychiatric Comorbidity With the Risk of Premature Death Among Children and Adults With Attention-Deficit/Hyperactivity Disorder.

Sun S, Kuja-Halkola R, Faraone SV, D'Onofrio BM, Dalsgaard S, Chang Z, Larsson H.

JAMA Psychiatry. 2019 Aug 7. doi: 10.1001/jamapsychiatry.2019.1944. [Epub ahead of print]

PMID:
31389973
10.

Quantifying the Protective Effects of Stimulants on Functional Outcomes in Attention-Deficit/Hyperactivity Disorder: A Focus on Number Needed to Treat Statistic and Sex Effects.

Biederman J, DiSalvo M, Fried R, Woodworth KY, Biederman I, Faraone SV.

J Adolesc Health. 2019 Jul 3. pii: S1054-139X(19)30305-2. doi: 10.1016/j.jadohealth.2019.05.015. [Epub ahead of print]

PMID:
31350122
11.

Systematic Review: Nonmedical Use of Prescription Stimulants: Risk Factors, Outcomes, and Risk Reduction Strategies.

Faraone SV, Rostain AL, Montano CB, Mason O, Antshel KM, Newcorn JH.

J Am Acad Child Adolesc Psychiatry. 2019 Jul 18. pii: S0890-8567(19)30470-8. doi: 10.1016/j.jaac.2019.06.012. [Epub ahead of print] Review.

12.

Is the endorsement of the Attention Deficit Hyperactivity Disorder symptom criteria ratings influenced by informant assessment, gender, age, and co-occurring disorders? A measurement invariance study.

Vitoratou S, Garcia-Rosales A, Banaschewski T, Sonuga-Barke E, Buitelaar J, Oades RD, Rothenberger A, Steinhausen HC, Taylor E, Faraone SV, Chen W.

Int J Methods Psychiatr Res. 2019 Jul 16:e1794. doi: 10.1002/mpr.1794. [Epub ahead of print]

PMID:
31310449
13.

Clinical correlates of mind wandering in adults with ADHD.

Biederman J, Lanier J, DiSalvo M, Noyes E, Fried R, Woodworth KY, Biederman I, Faraone SV.

J Psychiatr Res. 2019 Oct;117:15-23. doi: 10.1016/j.jpsychires.2019.06.012. Epub 2019 Jun 18.

PMID:
31272014
14.

Evidence of Low Adherence to Stimulant Medication Among Children and Youths With ADHD: An Electronic Health Records Study.

Biederman J, Fried R, DiSalvo M, Storch B, Pulli A, Woodworth KY, Biederman I, Faraone SV, Perlis RH.

Psychiatr Serv. 2019 Oct 1;70(10):874-880. doi: 10.1176/appi.ps.201800515. Epub 2019 Jun 27.

PMID:
31242830
15.

Prevalence and Consequences of the Nonmedical Use of Amphetamine Among Persons Calling Poison Control Centers.

Faraone SV, Hess J, Wilens T.

J Atten Disord. 2019 Sep;23(11):1219-1228. doi: 10.1177/1087054719843182. Epub 2019 Jun 6.

PMID:
31169052
16.

A Novel Text Message Intervention to Improve Adherence to Stimulants in Adults With Attention Deficit/Hyperactivity Disorder.

Biederman J, Fried R, DiSalvo M, Woodworth KY, Biederman I, Noyes E, Faraone SV, Perlis RH.

J Clin Psychopharmacol. 2019 Jul/Aug;39(4):351-356. doi: 10.1097/JCP.0000000000001055.

PMID:
31162154
17.

Sleep-Associated Adverse Events During Methylphenidate Treatment of Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis.

Faraone SV, Po MD, Komolova M, Cortese S.

J Clin Psychiatry. 2019 Apr 30;80(3). pii: 18r12210. doi: 10.4088/JCP.18r12210.

18.

A 9-Year Follow-Up of Attention-Deficit/Hyperactivity Disorder in a Population Sample.

Lecendreux M, Silverstein M, Konofal E, Cortese S, Faraone SV.

J Clin Psychiatry. 2019 May 7;80(3). pii: 18m12642. doi: 10.4088/JCP.18m12642.

PMID:
31087826
19.

Brain Imaging of the Cortex in ADHD: A Coordinated Analysis of Large-Scale Clinical and Population-Based Samples.

Hoogman M, Muetzel R, Guimaraes JP, Shumskaya E, Mennes M, Zwiers MP, Jahanshad N, Sudre G, Wolfers T, Earl EA, Soliva Vila JC, Vives-Gilabert Y, Khadka S, Novotny SE, Hartman CA, Heslenfeld DJ, Schweren LJS, Ambrosino S, Oranje B, de Zeeuw P, Chaim-Avancini TM, Rosa PGP, Zanetti MV, Malpas CB, Kohls G, von Polier GG, Seitz J, Biederman J, Doyle AE, Dale AM, van Erp TGM, Epstein JN, Jernigan TL, Baur-Streubel R, Ziegler GC, Zierhut KC, Schrantee A, Høvik MF, Lundervold AJ, Kelly C, McCarthy H, Skokauskas N, O'Gorman Tuura RL, Calvo A, Lera-Miguel S, Nicolau R, Chantiluke KC, Christakou A, Vance A, Cercignani M, Gabel MC, Asherson P, Baumeister S, Brandeis D, Hohmann S, Bramati IE, Tovar-Moll F, Fallgatter AJ, Kardatzki B, Schwarz L, Anikin A, Baranov A, Gogberashvili T, Kapilushniy D, Solovieva A, El Marroun H, White T, Karkashadze G, Namazova-Baranova L, Ethofer T, Mattos P, Banaschewski T, Coghill D, Plessen KJ, Kuntsi J, Mehta MA, Paloyelis Y, Harrison NA, Bellgrove MA, Silk TJ, Cubillo AI, Rubia K, Lazaro L, Brem S, Walitza S, Frodl T, Zentis M, Castellanos FX, Yoncheva YN, Haavik J, Reneman L, Conzelmann A, Lesch KP, Pauli P, Reif A, Tamm L, Konrad K, Oberwelland Weiss E, Busatto GF, Louza MR, Durston S, Hoekstra PJ, Oosterlaan J, Stevens MC, Ramos-Quiroga JA, Vilarroya O, Fair DA, Nigg JT, Thompson PM, Buitelaar JK, Faraone SV, Shaw P, Tiemeier H, Bralten J, Franke B.

Am J Psychiatry. 2019 Jul 1;176(7):531-542. doi: 10.1176/appi.ajp.2019.18091033. Epub 2019 Apr 24.

PMID:
31014101
20.

Effect of disease-associated SLC9A9 mutations on protein-protein interaction networks: implications for molecular mechanisms for ADHD and autism.

Zhang-James Y, Vaudel M, Mjaavatten O, Berven FS, Haavik J, Faraone SV.

Atten Defic Hyperact Disord. 2019 Mar;11(1):91-105. doi: 10.1007/s12402-018-0281-x. Epub 2019 Mar 29.

PMID:
30927234
21.

Advanced Paternal Age and Early Onset of Schizophrenia in Sporadic Cases: Not Confounded by Parental Polygenic Risk for Schizophrenia.

Wang SH, Hsiao PC, Yeh LL, Liu CM, Liu CC, Hwang TJ, Hsieh MH, Chien YL, Lin YT, Huang YT, Chen CY, Chandler SD, Faraone SV, Neale B, Glatt SJ, Tsuang MT, Hwu HG, Chen WJ.

Biol Psychiatry. 2019 Jul 1;86(1):56-64. doi: 10.1016/j.biopsych.2019.01.023. Epub 2019 Feb 7.

PMID:
30926130
22.

Genetic Markers of ADHD-Related Variations in Intracranial Volume.

Klein M, Walters RK, Demontis D, Stein JL, Hibar DP, Adams HH, Bralten J, Roth Mota N, Schachar R, Sonuga-Barke E, Mattheisen M, Neale BM, Thompson PM, Medland SE, Børglum AD, Faraone SV, Arias-Vasquez A, Franke B.

Am J Psychiatry. 2019 Mar 1;176(3):228-238. doi: 10.1176/appi.ajp.2018.18020149.

PMID:
30818988
23.

Are subsyndromal manifestations of attention deficit hyperactivity disorder morbid in children? A systematic qualitative review of the literature with meta-analysis.

Kirova AM, Kelberman C, Storch B, DiSalvo M, Woodworth KY, Faraone SV, Biederman J.

Psychiatry Res. 2019 Apr;274:75-90. doi: 10.1016/j.psychres.2019.02.003. Epub 2019 Feb 3.

PMID:
30780065
24.

An Integrated Analysis of Neural Network Correlates of Categorical and Dimensional Models of Attention-Deficit/Hyperactivity Disorder.

Pruim RHR, Beckmann CF, Oldehinkel M, Oosterlaan J, Heslenfeld D, Hartman CA, Hoekstra PJ, Faraone SV, Franke B, Buitelaar JK, Mennes M.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 May;4(5):472-483. doi: 10.1016/j.bpsc.2018.11.014. Epub 2018 Dec 20.

PMID:
30773473
25.

Sex Differences in Comorbidity Patterns of Attention-Deficit/Hyperactivity Disorder.

Ottosen C, Larsen JT, Faraone SV, Chen Q, Hartman C, Larsson H, Petersen L, Dalsgaard S.

J Am Acad Child Adolesc Psychiatry. 2019 Apr;58(4):412-422.e3. doi: 10.1016/j.jaac.2018.07.910. Epub 2019 Jan 8.

PMID:
30768399
26.

Comorbidity of bipolar I disorder and conduct disorder: a familial risk analysis.

Wozniak J, Wilens T, DiSalvo M, Farrell A, Wolenski R, Faraone SV, Biederman J.

Acta Psychiatr Scand. 2019 Apr;139(4):361-368. doi: 10.1111/acps.13013. Epub 2019 Mar 18.

PMID:
30758064
27.

Stimulant treatment profiles predicting co-occurring substance use disorders in individuals with attention-deficit/hyperactivity disorder.

Groenman AP, Schweren LJS, Weeda W, Luman M, Noordermeer SDS, Heslenfeld DJ, Franke B, Faraone SV, Rommelse N, Hartman CA, Hoekstra PJ, Buitelaar J, Oosterlaan J.

Eur Child Adolesc Psychiatry. 2019 Sep;28(9):1213-1222. doi: 10.1007/s00787-019-01283-y. Epub 2019 Feb 5.

28.

Disentangling polygenic associations between attention-deficit/hyperactivity disorder, educational attainment, literacy and language.

Verhoef E, Demontis D, Burgess S, Shapland CY, Dale PS, Okbay A, Neale BM, Faraone SV; iPSYCH-Broad-PGC ADHD Consortium, Stergiakouli E, Davey Smith G, Fisher SE, Børglum AD, St Pourcain B.

Transl Psychiatry. 2019 Jan 24;9(1):35. doi: 10.1038/s41398-018-0324-2.

29.

A General Framework for Assessing In vitro/In vivo Correlation as a Tool for Maximizing the Benefit-Risk Ratio of a Treatment Using a Convolution-Based Modeling Approach.

Gomeni R, Fang LL, Bressolle-Gomeni F, Spencer TJ, Faraone SV, Babiskin A.

CPT Pharmacometrics Syst Pharmacol. 2019 Feb;8(2):97-106. doi: 10.1002/psp4.12378. Epub 2019 Feb 5.

30.

Effort valuation and psychopathology in children and adults.

Nguyen NH, Albert AB, Van Orman S, Forken P, Blatt SD, Fremont WP, Faraone SV, Glatt SJ.

Psychol Med. 2019 Jan 14:1-7. doi: 10.1017/S0033291718003884. [Epub ahead of print]

PMID:
30636648
31.

Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality.

Soler Artigas M, Sánchez-Mora C, Rovira P, Richarte V, Garcia-Martínez I, Pagerols M, Demontis D, Stringer S; ADHD Group of the Psychiatric Genomics Consortium, International Cannabis Consortium, Vink JM, Børglum AD, Neale BM, Franke B, Faraone SV, Casas M, Ramos-Quiroga JA, Ribasés M.

Mol Psychiatry. 2019 Jan 4. doi: 10.1038/s41380-018-0339-3. [Epub ahead of print]

PMID:
30610198
32.

Substance use and nicotine dependence in persistent, remittent, and late-onset ADHD: a 10-year longitudinal study from childhood to young adulthood.

Ilbegi S, Groenman AP, Schellekens A, Hartman CA, Hoekstra PJ, Franke B, Faraone SV, Rommelse NNJ, Buitelaar JK.

J Neurodev Disord. 2018 Dec 27;10(1):42. doi: 10.1186/s11689-018-9260-y.

33.

The Adult ADHD Quality Measures Initiative.

Faraone SV, Silverstein MJ, Antshel K, Biederman J, Goodman DW, Mason O, Nierenberg AA, Rostain A, Stein MA, Adler LA.

J Atten Disord. 2019 Aug;23(10):1063-1078. doi: 10.1177/1087054718804354. Epub 2018 Dec 4.

PMID:
30511593
34.

The morbidity of subthreshold pediatric bipolar disorder: A systematic literature review and meta-analysis.

Vaudreuil CAH, Faraone SV, Di Salvo M, Wozniak JR, Wolenski RA, Carrellas NW, Biederman J.

Bipolar Disord. 2019 Feb;21(1):16-27. doi: 10.1111/bdi.12734. Epub 2018 Dec 19.

PMID:
30480855
35.

Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder.

Demontis D, Walters RK, Martin J, Mattheisen M, Als TD, Agerbo E, Baldursson G, Belliveau R, Bybjerg-Grauholm J, Bækvad-Hansen M, Cerrato F, Chambert K, Churchhouse C, Dumont A, Eriksson N, Gandal M, Goldstein JI, Grasby KL, Grove J, Gudmundsson OO, Hansen CS, Hauberg ME, Hollegaard MV, Howrigan DP, Huang H, Maller JB, Martin AR, Martin NG, Moran J, Pallesen J, Palmer DS, Pedersen CB, Pedersen MG, Poterba T, Poulsen JB, Ripke S, Robinson EB, Satterstrom FK, Stefansson H, Stevens C, Turley P, Walters GB, Won H, Wright MJ; ADHD Working Group of the Psychiatric Genomics Consortium (PGC); Early Lifecourse & Genetic Epidemiology (EAGLE) Consortium; 23andMe Research Team, Andreassen OA, Asherson P, Burton CL, Boomsma DI, Cormand B, Dalsgaard S, Franke B, Gelernter J, Geschwind D, Hakonarson H, Haavik J, Kranzler HR, Kuntsi J, Langley K, Lesch KP, Middeldorp C, Reif A, Rohde LA, Roussos P, Schachar R, Sklar P, Sonuga-Barke EJS, Sullivan PF, Thapar A, Tung JY, Waldman ID, Medland SE, Stefansson K, Nordentoft M, Hougaard DM, Werge T, Mors O, Mortensen PB, Daly MJ, Faraone SV, Børglum AD, Neale BM.

Nat Genet. 2019 Jan;51(1):63-75. doi: 10.1038/s41588-018-0269-7. Epub 2018 Nov 26.

36.

Need for further analysis to explore the association between ADHD and asthma - Authors' reply.

Cortese S, Sun S, Zhang J, Sharma E, Chang Z, Kuja-Halkola R, Almqvist C, Larsson H, Faraone SV.

Lancet Psychiatry. 2018 Dec;5(12):963-964. doi: 10.1016/S2215-0366(18)30395-X. No abstract available.

PMID:
30477652
37.

Genetic correlations among psychiatric and immune-related phenotypes based on genome-wide association data.

Tylee DS, Sun J, Hess JL, Tahir MA, Sharma E, Malik R, Worrall BB, Levine AJ, Martinson JJ, Nejentsev S, Speed D, Fischer A, Mick E, Walker BR, Crawford A, Grant SFA, Polychronakos C, Bradfield JP, Sleiman PMA, Hakonarson H, Ellinghaus E, Elder JT, Tsoi LC, Trembath RC, Barker JN, Franke A, Dehghan A; 23 and Me Research Team; Inflammation Working Group of the CHARGE Consortium; METASTROKE Consortium of the International Stroke Genetics Consortium; Netherlands Twin Registry; neuroCHARGE Working Group; Obsessive Compulsive and Tourette Syndrome Working Group of the Psychiatric Genomics Consortium, Faraone SV, Glatt SJ.

Am J Med Genet B Neuropsychiatr Genet. 2018 Oct;177(7):641-657. doi: 10.1002/ajmg.b.32652. Epub 2018 Oct 16.

38.

The Relationship Between Executive Function Deficits and DSM-5-Defined ADHD Symptoms.

Silverstein MJ, Faraone SV, Leon TL, Biederman J, Spencer TJ, Adler LA.

J Atten Disord. 2018 Oct 8:1087054718804347. doi: 10.1177/1087054718804347. [Epub ahead of print]

PMID:
30296883
39.

Role of conduct problems in the relation between Attention-Deficit Hyperactivity disorder, substance use, and gaming.

Schoenmacker GH, Groenman AP, Sokolova E, Oosterlaan J, Rommelse N, Roeyers H, Oades RD, Faraone SV, Franke B, Heskes T, Arias Vasquez A, Claassen T, Buitelaar JK.

Eur Neuropsychopharmacol. 2018 Oct 3. pii: S0924-977X(18)30156-1. doi: 10.1016/j.euroneuro.2018.06.003. [Epub ahead of print]

PMID:
30292416
40.

Brain scans from 21,297 individuals reveal the genetic architecture of hippocampal subfield volumes.

van der Meer D, Rokicki J, Kaufmann T, Córdova-Palomera A, Moberget T, Alnæs D, Bettella F, Frei O, Doan NT, Sønderby IE, Smeland OB, Agartz I, Bertolino A, Bralten J, Brandt CL, Buitelaar JK, Djurovic S, van Donkelaar M, Dørum ES, Espeseth T, Faraone SV, Fernández G, Fisher SE, Franke B, Haatveit B, Hartman CA, Hoekstra PJ, Håberg AK, Jönsson EG, Kolskår KK, Le Hellard S, Lund MJ, Lundervold AJ, Lundervold A, Melle I, Monereo Sánchez J, Norbom LC, Nordvik JE, Nyberg L, Oosterlaan J, Papalino M, Papassotiropoulos A, Pergola G, de Quervain DJF, Richard G, Sanders AM, Selvaggi P, Shumskaya E, Steen VM, Tønnesen S, Ulrichsen KM, Zwiers MP, Andreassen OA, Westlye LT; Alzheimer’s Disease Neuroimaging Initiative; Pediatric Imaging, Neurocognition and Genetics Study.

Mol Psychiatry. 2018 Oct 2. doi: 10.1038/s41380-018-0262-7. [Epub ahead of print]

41.

Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study.

Chen Q, Hartman CA, Haavik J, Harro J, Klungsøyr K, Hegvik TA, Wanders R, Ottosen C, Dalsgaard S, Faraone SV, Larsson H.

PLoS One. 2018 Sep 26;13(9):e0204516. doi: 10.1371/journal.pone.0204516. eCollection 2018.

42.

Establishing US norms for the Adult ADHD Self-Report Scale (ASRS-v1.1) and characterising symptom burden among adults with self-reported ADHD.

Adler LA, Faraone SV, Sarocco P, Atkins N, Khachatryan A.

Int J Clin Pract. 2019 Jan;73(1):e13260. doi: 10.1111/ijcp.13260. Epub 2018 Sep 21.

43.

Trajectories of psychiatric diagnoses and medication usage in youth with 22q11.2 deletion syndrome: a 9-year longitudinal study.

Kates WR, Mariano MA, Antshel KM, Chandra S, Gamble H, Giordano M, MacMaster E, Mattar M, St Fleur D, Faraone SV, Fremont WP.

Psychol Med. 2019 Aug;49(11):1914-1922. doi: 10.1017/S0033291718002696. Epub 2018 Sep 18.

PMID:
30226117
44.

Attention-deficit/hyperactivity disorder and clinically diagnosed obesity in adolescence and young adulthood: a register-based study in Sweden.

Chen Q, Hartman CA, Kuja-Halkola R, Faraone SV, Almqvist C, Larsson H.

Psychol Med. 2019 Aug;49(11):1841-1849. doi: 10.1017/S0033291718002532. Epub 2018 Sep 17.

PMID:
30220266
45.

Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan.

Franke B, Michelini G, Asherson P, Banaschewski T, Bilbow A, Buitelaar JK, Cormand B, Faraone SV, Ginsberg Y, Haavik J, Kuntsi J, Larsson H, Lesch KP, Ramos-Quiroga JA, Réthelyi JM, Ribases M, Reif A.

Eur Neuropsychopharmacol. 2018 Oct;28(10):1059-1088. doi: 10.1016/j.euroneuro.2018.08.001. Epub 2018 Sep 6. Review.

46.

Sirolimus for systemic lupus erythematosus - Authors' reply.

Perl A, Lai ZW, Kelly R, Faraone SV, Phillips PE.

Lancet. 2018 Sep 1;392(10149):734. doi: 10.1016/S0140-6736(18)31794-X. No abstract available.

PMID:
30191826
47.

Are Adult ADHD Patients Good Informants of Their Symptoms? A Qualitative Literature Review of Concordance Between Clinician and Self-Report ADHD Symptoms.

Abrams J, Faraone SV, Woodworth KY, Spencer TJ, Biederman I, Biederman J.

J Nerv Ment Dis. 2018 Sep;206(9):739-743. doi: 10.1097/NMD.0000000000000870. Review.

PMID:
30124570
48.

Further Evidence of Morbidity and Dysfunction Associated With Subsyndromal ADHD in Clinically Referred Children.

Biederman J, Fitzgerald M, Kirova AM, Woodworth KY, Biederman I, Faraone SV.

J Clin Psychiatry. 2018 Aug 7;79(5). pii: 17m11870. doi: 10.4088/JCP.17m11870.

PMID:
30086214
49.

The Course of Neurocognitive Functioning and Prediction of Behavioral Outcome of ADHD Affected and Unaffected Siblings.

van Lieshout M, Luman M, Schweren LJS, Twisk JWR, Faraone SV, Heslenfeld DJ, Hartman CA, Hoekstra PJ, Franke B, Buitelaar JK, Rommelse NNJ, Oosterlaan J.

J Abnorm Child Psychol. 2019 Mar;47(3):405-419. doi: 10.1007/s10802-018-0449-z.

50.

Association between attention deficit hyperactivity disorder and asthma: a systematic review and meta-analysis and a Swedish population-based study.

Cortese S, Sun S, Zhang J, Sharma E, Chang Z, Kuja-Halkola R, Almqvist C, Larsson H, Faraone SV.

Lancet Psychiatry. 2018 Sep;5(9):717-726. doi: 10.1016/S2215-0366(18)30224-4. Epub 2018 Jul 24.

PMID:
30054261

Supplemental Content

Loading ...
Support Center